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Objectives
To produce a thorough review of the existing state of
knowledge on sample size calculations for cluster rando-
mised trials (CRT’s) and to identify gaps in the
knowledge.
Methods
A systematic review is being conducted of sample size
methodology for cluster randomised trials. The sources
for the search include electronic databases PubMed and
Web of Science, key text books on cluster randomised
trials and discussions with experts in the field.
The search strategy involves a compliment of Medical
Subject Headings and free text terms to aid a compre-
hensive search. The references of papers eligible for the
review will also be searched and a search on the first
author conducted. This process will continue until no
more additional papers are located.
This work forms the beginning of a PhD research
project.
Results
Of 8697 citations obtained from PubMed and Web of
Science, the majority have currently been assessed for
eligibility into the review and 57 papers so far identified
for inclusion.
The majority of papers discuss sample size for contin-
uous or binary outcomes, with four papers discussing
time to event outcomes. In terms of the analysis method
used, most assume a random effects analysis (cluster
specific approach) or a cluster level analysis, with fewer
papers assuming a generalized estimating Equation
(population averaged approach) methodology.
An emerging theme, discussed in six papers, is sample
size methodology for 3-level cluster randomised trials,
where we may randomise clinics (level 3) and each clinic
will treat multiple subjects (level 2 units) who in turn
are measured on repeated occasions (level 1 units).
Eight papers consider sample size calculations for
trials with varying cluster sizes. These papers account
for the loss in power due to varying cluster sizes
through an examination of the relative efficiency of
unequal versus equal cluster sizes or by proposing an
appropriate design effect to account for this loss for
both continuous and binary outcomes.
Sample size for alternative trial designs such as cross-
over trials, stepped wedge designs, testing for non-infer-
iority, stratified, and matched designs were identified.
Papers covering adjustments to sample size for dealing
with non-compliance or attrition, accounting for the use
of cluster or person level covariates and dealing with
imprecision in the estimate of the intracluster correla-
tion coefficient (ICC) were identified.
Conclusion
We will provide the results of the search and prelimin-
ary insight into potential gaps in the knowledge.
Author details
1Centre for Primary Care and Public Health, Queen Mary University of
London, London, E1 2AB, UK. 2Hub for Trials Methodology Research, MRC
Clinical Trials Unit, London, UK.
Published: 13 December 2011
doi:10.1186/1745-6215-12-S1-A23
Cite this article as: Rutterford et al.: A review of methodology for
sample size calculations in cluster randomised trials. Trials 2011 12(Suppl
1):A23.
1Centre for Primary Care and Public Health, Queen Mary University of
London, London, E1 2AB, UK
Full list of author information is available at the end of the article
Rutterford et al. Trials 2011, 12(Suppl 1):A23
http://www.trialsjournal.com/content/12/S1/A23 TRIALS
© 2011 Rutterford et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
